EUVIMEDSkopri EUVIMED
Open access

Ferritin‐based nanocarrier delivery of KRAS G12D inhibitor in pancreatic adenocarcinoma cells and patient‐derived organoids: A novel approach for treatment

Annalisa Pia Abbinantefina, Claudia Tito, Silvia Masciarelli, Giada Tisci, Pierpaolo Ceci, Elisabetta Falvo, Veronica Ruta, Valentina Panzeri, Claudio Sette, Francesco Fazi iD, Gianni Colotti

Protein Science · 2026

DOI: 10.1002/pro.70444 ↗

At a glance

Journal article in Protein Science, 2026. Written by Annalisa Pia Abbinantefina and 10 co-authors. Institution: Department of Anatomical, Histological, Forensic & Orthopaedic Sciences, Section of Histology and Medical Embryology, Sapienza University of Rome, Ro…. Major MEDLINE topics: Proto-Oncogene Proteins p21(ras), Organoids, Pancreatic Neoplasms, Ferritins. 28 references. The full text is freely available in PubMed Central. Funded by: Next Generation EU, MUR. PRIN 2022, NextGenerationEU.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Activating KRAS mutations, particularly G12 variants, are key drivers in pancreatic ductal adenocarcinoma and other cancers. While KRAS was historically considered undruggable, mutant‐specific inhibitors, including non‐covalent KRAS G12D inhibitor MRTX1133, have emerged. However, efficacy and resistance remain challenges. We utilized a stimuli‐sensitive, ferritin‐derived nanomedicine platform to encapsulate high concentrations of MRTX1133, aiming for targeted delivery of the drug to KRAS‐mutated pancreatic ductal adenocarcinoma cells. This platform, designed for enhanced biodistribution and reduced off‐target effects, achieved a major efficacy over free MRTX1133 in 2D models regarding cell proliferation and KRAS inhibition pathway and, in 3D spheroid models, specifically concerning cell death. Efficacy in patient‐derived organoids was comparable. This study demonstrates the potential of this nanomedicine platform for targeted delivery of KRAS mutant‐specific inhibitors to human tumors.

Subjects

MeSH terms (MEDLINE)

Proto-Oncogene Proteins p21(ras)OrganoidsPancreatic NeoplasmsFerritinsDrug CarriersCarcinoma, Pancreatic DuctalAntineoplastic AgentsAdenocarcinomaHumansCell Line, TumorCell ProliferationMutation

Author keywords

KRAS G12DMRTX1133ferritin‐based nanocarrierpancreatic adenocarcinomapatient‐derived organoids

Substances

Proto-Oncogene Proteins p21(ras)KRAS protein, humanFerritinsDrug CarriersAntineoplastic Agents

Authors and institutions

  • Department of Anatomical, Histological, Forensic & Orthopaedic Sciences, Section of Histology and Medical Embryology, Sapienza University of Rome, Rome, Italy.
  • Institute of Molecular Biology and Pathology, Italian National Research Council, IBPM-CNR, Rome, Italy.
  • Department of Neuroscience, Section of Human Anatomy, Catholic University of the Sacred Heart, Rome, Italy.
  • GSTeP Organoids Research Core Facility, Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy.
  • Department of Wellbeing, Health and Environmental Sustainability (BeSSA), Sapienza University of Rome, Rieti, c/o Department of Anatomical, Histological, Forensic & Orthopaedic Sciences, Section of Histology and Medical…

ORCID profiles: Francesco Fazi

Funding

  • Next Generation EU
  • MUR. PRIN 2022
  • NextGenerationEU

Cite

APA

Abbinantefina, A. P., Tito, C., Masciarelli, S., Tisci, G., Ceci, P., Falvo, E., Ruta, V., Panzeri, V., Sette, C., Fazi, F., & Colotti, G. (2026). Ferritin‐based nanocarrier delivery of KRAS G12D inhibitor in pancreatic adenocarcinoma cells and patient‐derived organoids: A novel approach for treatment. Protein Science. https://doi.org/10.1002/pro.70444

Vancouver

Abbinantefina AP, Tito C, Masciarelli S, Tisci G, Ceci P, Falvo E, et al. Ferritin‐based nanocarrier delivery of KRAS G12D inhibitor in pancreatic adenocarcinoma cells and patient‐derived organoids: A novel approach for treatment. Protein Science. 2026. doi:10.1002/pro.70444

BibTeX
@article{Abbinantefina2026,
  author = {Abbinantefina, Annalisa Pia and Tito, Claudia and Masciarelli, Silvia and Tisci, Giada and Ceci, Pierpaolo and Falvo, Elisabetta and Ruta, Veronica and Panzeri, Valentina and Sette, Claudio and Fazi, Francesco and Colotti, Gianni},
  title = {Ferritin‐based nanocarrier delivery of KRAS G12D inhibitor in pancreatic adenocarcinoma cells and patient‐derived organoids: A novel approach for treatment},
  journal = {Protein Science},
  year = {2026},
  doi = {10.1002/pro.70444}
}
Start for free →